Viewing Study NCT00447694

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:40 AM
Ignite Modification Date: 2026-01-25 @ 6:26 AM
Study NCT ID: NCT00447694
Status: COMPLETED
Last Update Posted: 2021-06-14
First Post: 2007-03-13
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Cardiac T2* in Beta-thalassemia Patients on Deferasirox Treatment
Sponsor: Novartis
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Beta-thalassemia View
None Iron Overload View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Iron Chelation View
None Deferasirox View
None Chelator View
None Desferal View
None beta-thalassemia View
None Iron overload View